
New data have resulted in updated guidelines for neoadjuvant cemiplimab.
New data have resulted in updated guidelines for neoadjuvant cemiplimab.
Pharmacists can improve both quality of life and financial toxicity for patients.
Pharmacists also have the resources to help advocate for better care for patients.
Precision therapies, although effective in earlier stages, may not work later.
After carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Pharmacists will play a significant role in TKI adherence rates among patients.
There is much to be learned and progress to be made in all these efforts toward the optimization of tolerability, safety, and efficacy of oncologic therapies.